The ROE (Return on Equity) of Relmada Therapeutics Inc (RLMD) is -225.15%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -225.15% |
| 2023-12-31 | -115.74% |
| 2022-12-31 | -111.85% |
| 2021-12-31 | -60.37% |
| 2020-12-31 | -56.31% |
| 2019-06-30 | -14.97% |
| 2018-06-30 | -117.89% |
| 2017-06-30 | 114.36% |
| 2016-06-30 | -198.00% |
| 2015-06-30 | -297.14% |